CD2 and cancer: Certainly, an integrative data-driven approach to identify cancer cell programs associated with T-cell exclusion has revealed that the lack of physical interaction between cancer cells and immune cells, including MHC-I-TCR and CD2-CD58, is a prominent feature of the resistance program155.